Actively Recruiting

All Genders
NCT07418099

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

Led by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Updated on 2026-05-01

1500

Participants Needed

16

Research Sites

58 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prolonged activated partial thromboplastin time (APTT) is a frequent laboratory finding that may reflect a broad spectrum of underlying conditions, ranging from benign laboratory abnormalities to clinically relevant hemostatic disorders. Clot waveform analysis (CWA), automatically generated during routine APTT testing by optical coagulation analyzers, provides additional quantitative and qualitative information on clot formation dynamics. The APTTO model is a previously developed two-step predictive algorithm based on CWA features designed to estimate the probability of a pathological cause of prolonged APTT and to differentiate lupus anticoagulant from intrinsic pathway factor deficiency or von Willebrand disease. Internal validation has demonstrated good discrimination and calibration. This multicenter observational study aims to perform an external validation of the APTTO model in independent patient cohorts, assessing its discrimination, calibration, and decision-analytic performance without model updating.

CONDITIONS

Official Title

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients of any age, including pediatric and adult, undergoing coagulation testing with prolonged APTT (APTT ratio 21 1.25)
  • Normal prothrombin time (PT) based on local lab reference ranges
  • Availability of clot waveform analysis data from routine APTT testing using optical coagulation analyzers (ACL TOP platform) and silica-based APTT reagent (SynthASil�ae)
  • Completion of standard laboratory evaluation for prolonged APTT as part of routine care when indicated
  • Samples collected and processed following the standardized preanalytical protocol in the study SOP
  • Patients evaluated during preoperative assessment or routine clinical practice (non-preoperative)
Not Eligible

You will not qualify if you...

  • Prolonged prothrombin time (PT) or combined prolongation of PT and APTT
  • Inadequate preanalytical conditions, including incorrect blood-to-anticoagulant ratio, delayed plasma processing, inadequate centrifugation or plasma quality
  • Absence of required clot waveform analysis data or unavailable clot waveform images
  • Samples with APTT values outside the measurable range of the analyzer preventing parameter extraction
  • Missing essential clinical or laboratory data needed for applying the APTTO models

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

Hospital Universitario Severo Ochoa

Leganés, Madrid, Spain

Actively Recruiting

2

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Actively Recruiting

3

Hospital Universitario Arnau De Vilanova

Lleida, Spain

Actively Recruiting

4

Hospital Universitario 12 de Octubre

Madrid, Spain

Actively Recruiting

5

Hospital Universitario Clínico San Carlos

Madrid, Spain

Not Yet Recruiting

6

Hospital Universitario Fundación Jiménez Díaz

Madrid, Spain

Actively Recruiting

7

Hospital Universitario Gregorio Marañón

Madrid, Spain

Not Yet Recruiting

8

Hospital Universitario Puerta de Hierro

Madrid, Spain

Not Yet Recruiting

9

Hospital Universitario Ramón y Cajal

Madrid, Spain

Actively Recruiting

10

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, Spain

Not Yet Recruiting

11

Clínica Universidad de Navarra

Pamplona, Spain

Not Yet Recruiting

12

Hospital Clínico Universitario de Salamanca

Salamanca, Spain

Not Yet Recruiting

13

Complexo Hospitalario Universitario de Santiago

Santiago de Compostela, Spain

Not Yet Recruiting

14

Hospital Clínico Universitario de Valladolid

Valladolid, Spain

Actively Recruiting

15

Complexo Hospitalario Universitario De Vigo

Vigo, Spain

Not Yet Recruiting

16

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Spain

Not Yet Recruiting

Loading map...

Research Team

D

Diego Velasco Rodríguez, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here